| SEGMENTS OF OPERATIONS |
NOTE 7 – SEGMENTS OF OPERATIONS The Company’s chief operating decision maker is the Company’s Chief Executive Officer (the “CODM”), who makes resource allocation decisions and assesses performance based on financial information prepared on a consolidated basis, accompanied by disaggregated information about revenues, gross profit (loss) and operating loss by the three identified reportable segments. The CODM uses gross profit (loss) and operating loss for each segment predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for all measures when making decisions about the allocation of operating and capital resources to each segment. The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable operating segments. The Company manages its business primarily on a service basis. The Company’s reportable segments consist of the Nanox.ARC division, the radiology services division and the AI and software solutions division. Each one is managed separately to better align with the Company’s customers and distribution partners and the unique market dynamics of each segment. Operating loss for each segment includes revenues from third parties, related cost of revenues and operating expenses directly attributable to the segment. The Company does not include intercompany transfers between segments for management reporting. Nanox health IT Inc.’s operational results are included in the AI and software solutions segment. The accounting policies of the various segments are the same as those described in Note 2, “Summary of Significant Accounting Policies” in the Annual Report. | | | Six months ended June 30, 2026 | | | | | Nanox. ARC | | | Radiology Services | | | AI and Software Solutions | | | Total | | | Revenues | | | 329 | | | | 6,055 | | | | (*) 2,083 | | | | 8,467 | | | Cost of revenues | | | 3,713 | | | | 4,785 | | | | 5,536 | | | | 14,034 | | | Cost of revenues – Impairment of intangible assets | | | - | | | | - | | | | 40,695 | | | | 40,695 | | | Segment gross profit (loss) | | | (3,384 | ) | | | 1,270 | | | | (44,148 | ) | | | (46,262 | ) | | Research and development, net | | | 7,253 | | | | 64 | | | | 2,188 | | | | 9,505 | | | Sales and Marketing | | | 3,175 | | | | 265 | | | | 624 | | | | 4,064 | | | General and administrative | | | 9,037 | | | | 919 | | | | 728 | | | | 10,684 | | | Other segment items (**) | | | (507 | ) | | | - | | | | 27 | | | | (480 | ) | | Segment operating profit (loss) | | | (22,342 | ) | | | 22 | | | | (47,715 | ) | | | (70,035 | ) | | Financial income (expense), net | | | | | | | | | | | | | | | 308 | | | Loss before taxes on income | | | | | | | | | | | | | | | (69,727 | ) | | | | | | | | | | | | | | | | | | | | Depreciation expense | | | 576 | | | | 4 | | | | 49 | | | | 629 | | | Amortization expense | | | - | | | | 990 | | | | 4,019 | | | | 5,009 | | | Stock based compensation | | | 1,310 | | | | 302 | | | | 98 | | | | 1,710 | | | | | | | | | | | | | | | | | | | | | Total Assets | | | 67,551 | | | | 19,174 | | | | 4,460 | | | | 91,185 | | | Expenditures for segment’s assets | | | 2,761 | | | | - | | | | - | | | | 2,761 | | | (*) | Including $1,844 thousand related to Nanox Health IT Inc. | | (**) | Nanox.ARC - loss from disposal of property and equipment, rent income and remeasurement of a settlement with a shareholder. | AI and Software Solutions - change in the fair value of earn out liability obligation. | | | Six months ended June 30, 2025 | | | | | Nanox. ARC | | | Radiology Services | | | AI and Software Solutions | | | Total | | | Revenues | | | 254 | | | | 5,328 | | | | 273 | | | | 5,855 | | | Cost of revenues | | | 3,570 | | | | 4,402 | | | | 4,172 | | | | 12,144 | | | Segment gross profit (loss) | | | (3,316 | ) | | | 926 | | | | (3,899 | ) | | | (6,289 | ) | | Research and development, net | | | 7,546 | | | | 65 | | | | 2,201 | | | | 9,812 | | | Sales and Marketing | | | 1,885 | | | | 208 | | | | 85 | | | | 2,178 | | | General and administrative | | | 8,522 | | | | 1,606 | | | | 137 | | | | 10,265 | | | Other segment items (*) | | | 37 | | | | - | | | | - | | | | 37 | | | Segment operating loss | | | (21,306 | ) | | | (953 | ) | | | (6,322 | ) | | | (28,581 | ) | | Financial income (expense), net | | | | | | | | | | | | | | | 616 | | | Loss before taxes on income | | | | | | | | | | | | | | | (27,965 | ) | | | | | | | | | | | | | | | | | | | | Depreciation expense | | | 530 | | | | 4 | | | | 52 | | | | 586 | | | Amortization expense | | | - | | | | 1,314 | | | | 3,992 | | | | 5,306 | | | Stock based compensation | | | 1,817 | | | | 370 | | | | 90 | | | | 2,277 | | | | | | | | | | | | | | | | | | | | | Total Assets | | | 111,972 | | | | 18,774 | | | | 53,486 | | | | 184,232 | | | Expenditures for segment’s assets | | | 1,569 | | | | 10 | | | | - | | | | 1,579 | | | (*) | Nanox.ARC – loss from disposal of property and equipment and rent income. | | | | Three months ended June 30, 2026 | | | | | Nanox. ARC | | | Radiology Services | | | AI and Software Solutions | | | Total | | | Revenues | | | 162 | | | | 2,950 | | | | (*) 1,044 | | | | 4,156 | | | Cost of revenues | | | 1,948 | | | | 2,077 | | | | 3,110 | | | | 7,135 | | | Cost of revenues – Impairment of intangible assets | | | - | | | | - | | | | 40,695 | | | | 40,695 | | | Segment gross profit (loss) | | | (1,786 | ) | | | 873 | | | | (42,761 | ) | | | (43,674 | ) | | Research and development, net | | | 3,565 | | | | 28 | | | | 1,114 | | | | 4,707 | | | Sales and Marketing | | | 1,445 | | | | 56 | | | | 399 | | | | 1,900 | | | General and administrative | | | 4,563 | | | | 458 | | | | 423 | | | | 5,444 | | | Other segment items (**) | | | (247 | ) | | | - | | | | (1 | ) | | | (248 | ) | | Segment operating profit (loss) | | | (11,112 | ) | | | 331 | | | | (44,696 | ) | | | (55,477 | ) | | Financial income (expense), net | | | | | | | | | | | | | | | (61 | ) | | Loss before taxes on income | | | | | | | | | | | | | | | (55,538 | ) | | | | | | | | | | | | | | | | | | | | Depreciation expense | | | 286 | | | | 3 | | | | 25 | | | | 314 | | | Amortization expense | | | - | | | | 495 | | | | 2,009 | | | | 2,505 | | | Stock based compensation | | | 664 | | | | 157 | | | | 48 | | | | 869 | | | (*) | Including $934 thousand related to Nanox Health IT Inc. | | (**) | Nanox.ARC – loss from disposal of property and equipment, rent income and remeasurement of a settlement with a shareholder. | AI and Software Solutions - change in the fair value of earn out liability obligation. | | | Three months ended June 30, 2025 | | | | | Nanox. ARC | | | Radiology Services | | | AI and Software Solutions | | | Total | | | Revenues | | | 221 | | | | 2,723 | | | | 96 | | | | 3,040 | | | Cost of revenues | | | 1,961 | | | | 2,242 | | | | 2,077 | | | | 6,280 | | | Segment gross profit (loss) | | | (1,740 | ) | | | 481 | | | | (1,981 | ) | | | (3,240 | ) | | Research and development, net | | | 3,759 | | | | 36 | | | | 1,039 | | | | 4,834 | | | Sales and Marketing | | | 1,066 | | | | 110 | | | | 63 | | | | 1,239 | | | General and administrative | | | 4,322 | | | | 734 | | | | 71 | | | | 5,127 | | | Other segment items (*) | | | 51 | | | | - | | | | - | | | | 51 | | | Segment operating loss | | | (10,938 | ) | | | (399 | ) | | | (3,154 | ) | | | (14,491 | ) | | Financial income (expense), net | | | | | | | | | | | | | | | (149 | ) | | Loss before taxes on income | | | | | | | | | | | | | | | (14,640 | ) | | | | | | | | | | | | | | | | | | | | Depreciation expense | | | 270 | | | | 2 | | | | 27 | | | | 299 | | | Amortization expense | | | - | | | | 657 | | | | 1,996 | | | | 2,653 | | | Stock based compensation | | | 882 | | | | 186 | | | | 43 | | | | 1,111 | | | (*) | Nanox.ARC – loss from disposal of property and equipment and rent income. | As of June 30, 2026 and December 31, 2025, no individual customer exceeded 10% of the Company’s accounts receivables.
|